An alternative to pharmaceutical pay-for-delay deals
A new paper has suggested that pay-for-delay deals could be…
A new paper has suggested that pay-for-delay deals could be replaced with a challenger-based system to improve access to generic drugs.
List view / Grid view
A new paper has suggested that pay-for-delay deals could be…
A new paper has suggested that pay-for-delay deals could be replaced with a challenger-based system to improve access to generic drugs.
The changes could prevent anticompetitive practices between branded and generic…
The changes could prevent anticompetitive practices between branded and generic pharmaceutical manufacturers, lowering drug prices for consumers.